GHRS
Price
$9.52
Change
+$0.02 (+0.21%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
589.27M
19 days until earnings call
ORMP
Price
$2.33
Change
+$0.03 (+1.30%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
93.96M
33 days until earnings call
Ad is loading...

GHRS vs ORMP

Header iconGHRS vs ORMP Comparison
Open Charts GHRS vs ORMPBanner chart's image
GH Research
Price$9.52
Change+$0.02 (+0.21%)
Volume$1.99K
Capitalization589.27M
Oramed Pharmaceuticals
Price$2.33
Change+$0.03 (+1.30%)
Volume$100
Capitalization93.96M
GHRS vs ORMP Comparison Chart
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. ORMP commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Buy and ORMP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (GHRS: $9.50 vs. ORMP: $2.30)
Brand notoriety: GHRS and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 97% vs. ORMP: 20%
Market capitalization -- GHRS: $589.27M vs. ORMP: $93.96M
GHRS [@Biotechnology] is valued at $589.27M. ORMP’s [@Biotechnology] market capitalization is $93.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • GHRS’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, both GHRS and ORMP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • GHRS’s TA Score: 5 bullish, 5 bearish.
  • ORMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than GHRS.

Price Growth

GHRS (@Biotechnology) experienced а +4.40% price change this week, while ORMP (@Biotechnology) price change was +6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

Reported Earning Dates

GHRS is expected to report earnings on Aug 20, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($589M) has a higher market cap than ORMP($94M). GHRS YTD gains are higher at: 35.714 vs. ORMP (-4.959). ORMP has higher annual earnings (EBITDA): 9.44M vs. GHRS (-38.6M). GHRS (149M) and ORMP (142M) have equal amount of cash in the bank . ORMP has less debt than GHRS: ORMP (429K) vs GHRS (624K). GHRS (0) and ORMP (0) have equivalent revenues.
GHRSORMPGHRS / ORMP
Capitalization589M94M627%
EBITDA-38.6M9.44M-409%
Gain YTD35.714-4.959-720%
P/E RatioN/A20.91-
Revenue00-
Total Cash149M142M105%
Total Debt624K429K145%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRSORMP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVRX13.93N/A
N/A
Lord Abbett Fundamental Equity R3
LMESX32.24N/A
N/A
ClearBridge Appreciation IS
PCGRX21.51N/A
N/A
Victory Pioneer Mid Cap Value A
SLCGX25.65N/A
N/A
Saratoga Large Capitalization Growth I
GABVX10.01N/A
N/A
Gabelli Value 25 A

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
N/A
MDGL - GHRS
43%
Loosely correlated
+3.61%
IVVD - GHRS
39%
Loosely correlated
+3.74%
ATAI - GHRS
36%
Loosely correlated
+0.66%
IBRX - GHRS
31%
Poorly correlated
N/A
ORMP - GHRS
31%
Poorly correlated
-0.43%
More